Literature DB >> 11577027

Potentiation of Ca(2+) release by cADP-ribose in the heart is mediated by enhanced SR Ca(2+) uptake into the sarcoplasmic reticulum.

V Lukyanenko1, I Györke, T F Wiesner, S Györke.   

Abstract

cADP-Ribose (cADPR) is a novel endogenous messenger that is believed to mobilize Ca(2+) from ryanodine-sensitive Ca(2+) stores. Despite intense research, the precise mechanism of action of cADPR remains uncertain, and experimental findings are contradictory. To elucidate the mechanism of cADPR action, we performed confocal Ca(2+) imaging in saponin-permeabilized rat ventricular myocytes. Exposure of the cells to cADPR resulted in a slow (>2 minutes) and steady increase in the frequency of Ca(2+) sparks. These effects on local release events were accompanied by a significant increase in sarcoplasmic reticulum (SR) Ca(2+) content. In comparison, sensitization of ryanodine receptors (RyRs) by caffeine, a true RyR agonist, caused a rapid (<1 second) and transient potentiation of Ca(2+) sparks followed by a decrease in SR Ca(2+) content. When the increase in the SR load was prevented by partial inhibition of the SR Ca(2+) with thapsigargin, cADPR failed to produce any increase in sparking activity. cADPR had no significant impact on activity of single cardiac RyRs incorporated into lipid bilayers. However, it caused a significant increase in the rate of Ca(2+) uptake by cardiac SR microsomes. Our results suggest that the primary target of cADPR is the SR Ca(2+) uptake mechanism. Potentiation of Ca(2+) release by cADPR is mediated by increased accumulation of Ca(2+) in the SR and subsequent luminal Ca(2+)-dependent activation of RyRs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577027     DOI: 10.1161/hh1901.098066

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Modulation of endoplasmic reticulum Ca2+ store filling by cyclic ADP-ribose promotes inositol trisphosphate (IP3)-evoked Ca2+ signals.

Authors:  Michiko Yamasaki-Mann; Angelo Demuro; Ian Parker
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes.

Authors:  Chengju Tian; Chun Hong Shao; Caronda J Moore; Shelby Kutty; Timothy Walseth; Cyrus DeSouza; Keshore R Bidasee
Journal:  Cardiovasc Res       Date:  2011-03-18       Impact factor: 10.787

3.  Cytosolic [Ca2+] regulation of InsP3-evoked puffs.

Authors:  Michiko Yamasaki-Mann; Angelo Demuro; Ian Parker
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

4.  Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca2+ handling in ageing rabbit hearts.

Authors:  Leroy L Cooper; Weiyan Li; Yichun Lu; Jason Centracchio; Radmila Terentyeva; Gideon Koren; Dmitry Terentyev
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

Review 5.  Mitochondria in cardiomyocyte Ca2+ signaling.

Authors:  Valeriy Lukyanenko; Aristide Chikando; W J Lederer
Journal:  Int J Biochem Cell Biol       Date:  2009-04-02       Impact factor: 5.085

6.  Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.

Authors:  Xu Zhang; Yvonne N Tallini; Zheng Chen; Lu Gan; Bin Wei; Robert Doran; Lin Miao; Hong-Bo Xin; Michael I Kotlikoff; Guangju Ji
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

7.  cADPR stimulates SERCA activity in Xenopus oocytes.

Authors:  Michiko Yamasaki-Mann; Angelo Demuro; Ian Parker
Journal:  Cell Calcium       Date:  2009-01-07       Impact factor: 6.817

Review 8.  Calcium Signaling in Cardiomyocyte Function.

Authors:  Guillaume Gilbert; Kateryna Demydenko; Eef Dries; Rosa Doñate Puertas; Xin Jin; Karin Sipido; H Llewelyn Roderick
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

Review 9.  Emerging potential benefits of modulating NAD+ metabolism in cardiovascular disease.

Authors:  Daniel S Matasic; Charles Brenner; Barry London
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

Review 10.  CD38: A Potential Therapeutic Target in Cardiovascular Disease.

Authors:  Wanyun Zuo; Na Liu; Yunhong Zeng; Yaozhong Liu; Biao Li; Keke Wu; Yunbin Xiao; Qiming Liu
Journal:  Cardiovasc Drugs Ther       Date:  2021-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.